Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched Multicenter Cohort Study

PURPOSE: To compare long-term disease-free survival (DFS) between patients receiving tegafur/gimeracil/oteracil (S-1) or capecitabine plus oxaliplatin (CAPOX) adjuvant chemotherapy (AC) for gastric cancer (GC). MATERIALS AND METHODS: This retrospective multicenter observational study enrolled 983 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chang Min, Yoo, Moon-Won, Son, Young-Gil, Oh, Sung Jin, Kim, Jong-Han, Kim, Hyoung-Il, Park, Joong-Min, Hur, Hoon, Jee, Ye Seob, Hwang, Sun-Hwi, Jin, Sung-Ho, Lee, Sang Eok, Park, Ji-Ho, Seo, Kyung Won, Park, Sungsoo, Kim, Chang Hyun, Jeong, In Ho, Lee, Han Hong, Choi, Sung Il, Lee, Sang-Il, Kim, Chan Young, Kim, In-Hwan, Son, Myoung-Won, Pak, Kyung Ho, Kim, Sungsoo, Lee, Moon-Soo, Min, Jae-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311213/
https://www.ncbi.nlm.nih.gov/pubmed/32595999
http://dx.doi.org/10.5230/jgc.2020.20.e13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311213/
https://www.ncbi.nlm.nih.gov/pubmed/32595999
http://dx.doi.org/10.5230/jgc.2020.20.e13

Ejemplares similares